US Patent Issued to Genentech on Jan. 28 for "Pyridine-sulfonamide derivatives as sodium channel inhibitors" (Canadian, American, Chinese Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,075, issued on Jan. 28, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Pyridine-sulfonamide derivatives as sodium channel inhibitors" was invented by Steven McKerrall (South San Francisco, Calif.), Ramsay Beveridge (Quebec, Canada), Kwong Wah Lai (Shanghai) and Philippe Bergeron (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables Y1-Y6, X, Z, Z1, Z2, R2-R3, and R6 have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositio...